ArticleTranslational andrology and urology2025
Penile cancer awareness and knowledge among adult patients in an ambulatory urology clinic.
Article in Translational andrology and urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Diagnostic and treatment delays in penile cancer: a call to improve awareness and referral.World journal of urology · 2026Article
- Awareness and Knowledge of Penile Cancer Among University Students in Ghana.American journal of men's healthArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Penile cancer (PeCa) is a rare urologic malignancy in the United States, and public awareness remains low. In this brief report, we design and execute a survey to evaluate knowledge and awareness of PeCa focusing on general PeCa knowledge, treatment options, and willingness to recommend a preventative intervention. Study participants were recruited with a study flyer from the waiting room of two Los Angeles community-based urology clinics. All patients were English-speaking and over 18 years old. Study recruitment took place from October 2021 to June 2022 and 83 participants were included. The majority of respondents were men (90%) and white (87%), with a mean age 63 years. Ninety-eight percent of respondents reported either knowing "nothing" or "a little" about PeCa; 69% of respondents did not know a person could get cancer on the penis. Knowledge of risk factors for PeCa was particularly poor, with respect to phimosis (5% correctly identified this as a risk factor), balanitis (28%), and human papilloma virus (HPV) (44%). The majority of respondents, however, reported that they would recommend administration of an HPV vaccine for the prevention of PeCa (89%) once informed of HPV as a risk factor. Our findings underscore the lack of knowledge and awareness of PeCa, which may contribute to future delays in care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.